Advertisement

Paroxysmal Nocturnal Hemoglobinuria PNH - Biotech, Pharma and Life Science Channel

18:48 EDT 22nd May 2013 | BioPortfolio

PubMed Articles [ 697 Associated PubMed Articles listed on BioPortfolio]

The HATCH and CHA2DS 2-VASc scores : Prognostic value in pulmonary vein isolation.

AIMS: The HATCH score describes the risk of paroxysmal atrial fibrillation (Afib) progression, while the CHA2DS2vasc score depicts the risk of thromboembolic events in patients with Afib. We hypothesi...

Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis.

Primary nocturnal enuresis is a prevalent childhood condition that can persist into adulthood. Desmopressin is an antidiuretic available as orally disintegrating lyophilisate (melt) or solid tablet. R...

Safety and Effectiveness of Insulin Aspart in Basal-Bolus Regimens Regardless of Age: A1chieve Study Results.

INTRODUCTION: Hypoglycemia is a complication in the management of type 2 diabetes, and elderly people are at greater risk of experiencing hypoglycemia events than younger patients. Insulin analogs ach...

Safety and Effectiveness of Insulin Detemir in Different Age-Groups in the A1chieve Study.

INTRODUCTION: Diabetes therapy should balance glycemic control with risk of adverse events. This sub-analysis of the A1chieve study evaluated clinical safety and effectiveness of insulin detemir in di...

Effect of amphetamine on the clock gene expression in rat striatum.

Drug addicts have severe disruptions in many physiological and behavioral rhythms, such as the sleep/wake cycle. Interestingly, amphetamine, a psychostimulant, is able to alter many circadian patterns...

Phenotypic characteristics of resistant hypertension in the Brazilian population.

Resistant hypertension (RH) is defined as blood pressure that remains above target in spite of the concurrent use of three or more classes of antihypertensive drugs at optimized doses (UCRH), with one...

Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers.

OBJECTIVE: This study aimed to evaluate the effects of repeated treatments with the sedative antidepressants mirtazapine and trazodone on driving performance and cognitive function. METHODS: Nineteen...

Puerarin-induced immune hemolytic anemia.

Drug-induced immune hemolytic anemia (DIIHA) is a relatively uncommon condition characterized by a sudden drop in hemoglobin, putatively following exposure to drugs. Severe forms of hemolysis characte...

CPAP therapy prevents increase in blood pressure after upper airway surgery for obstructive sleep apnoea.

OBJECTIVE: The aim of this study was to investigate the efficacy of continuous positive airway pressure (CPAP) therapy following uvulopalatopharyngoplasty (UPPP) to prevent blood pressure (BP) elevati...

Imidafenacin for the treatment of overactive bladder.

Introduction: Imidafenacin (KRP-197/ONO-8025) is the latest antimuscarinic (AM) developed for the treatment of overactive bladder syndrome (OAB) and, at the moment, it is marketed only in Japan. This...

News Articles [ 142 Associated News Articles listed on BioPortfolio]

New Zealand declines Alexion's funding application for Solaris

New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to decline the application from USA-based drugmaker Alexion Pharmaceuticals (Nasdaq: ALXN) for funding its drug...

The best part of my job.

I love my job, but the best part of my job is connecting rare disease patients. I was hired in June of 2011 to manage RareConnect- NORD’s global, online communities project with EURORDIS. About eigh...

Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

UCB today announced data from a double-blind, placebo-controlled study that found that Neupro (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure elevations associated with...

New study shows UCB's Neupro reduces NSBP in RLS patient

Leading Belgian drugmaker UCB (Euronext Brussels: UCB) today (May 17) announced data from a double-blind, placebo-controlled study that found that Neupro (rotigotine transdermal system) reduced total...

UCB unveils effects of Neupro on cardiovascular measures in RLS patients

UCB has unveiled data from a double-blind, placebo-controlled study, which found that Neupro (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure (NSBP) elevations associate...

Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL® SMARTTOUCH™ Catheter

THERMOCOOL® SMARTTOUCH™ Catheter and Software Module Enables Contact Force Sensing in the Ablation of Atrial Fibrillation Biosense Webster, Inc., a worldwi...

Repeat Ablation for Recurrent Paroxysmal AF, Not Drugs

Not only was reablation more likely to banish recurrences in a randomized study, trying drugs the second time just made it worse for some patients. Heartwire

Endosense Underscores Significance of Contact Force Parameters with New Study Data at Heart Rhythm 2013

Endosense, a pioneer and leader in contact force (CF) technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias,...

Willowbrook Area Dialysis Center Introduces Medical Directors and Staff at Open House and Family Day

Houston, TX (PRWEB) May 13, 2013 Dialyspa, an innovator in hemodialysis , home dialysis, peritoneal dialysis and nocturnal dialysis, invites the community to visit their newest dialysis center for...

Repeat Procedure Bests Meds After Failed Ablation (CME/CE)

DENVER (MedPage Today) -- When ablation fails to eliminate paroxysmal atrial fibrillation, a second try is more successful than medication alone, a clinical trial showed.

Events [0 Results]

None

Companies [0 Results]

None

Clinical Trials [ 160 Associated Clinical Trials listed on BioPortfolio]

Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)

The purpose of this study is to demonstrate the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact (HeartLight) in the treatment of atrial fibrill...

A 6-Week Open Label Cross-Over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)

To evaluate the preference of subjects for Minirin® oral lyophilisate treatment compared with Minirin® tablet treatment after 6 weeks. To compare efficacy of the 2 formulations at the e...

Insulin Glulisine in Diabetes Mellitus, Type 2

Primary objective: The primary study objective is to demonstrate superior efficacy of an intensified insulin regimen with insulin glulisine and insulin glargine to a two-injection convent...

Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria

This study will evaluate the safety and effectiveness of the experimental drug eculizumab for treating paroxysmal nocturnal hemoglobinuria (PNH), a disorder that can cause premature destru...

Effects of NIMV on the Health Status of Chronic Obstructive Pulmonary Disease (COPD )Patients

In this proposal, we will implement a randomized controlled trial to determine whether nocturnal NIMV applied for 3 months: 1) improves (disease-specific) health related quality of life (...

Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation

Hypothesis: Blocking the angiotensin (AT) II type 1 receptor (Olmesartan) reduces the incidence of episodes of atrial fibrillation in patients with paroxysmal atrial fibrillation during 1...

Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children

The primary objective of this study is to compare the QVAR-Easi-Breathe 100 mcg/day and QVAR-Easi-Breathe 200 mcg/day with placebo relative to changes in forced expiratory volume in 1 seco...

Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

Severe aplastic anemia, characterized by pancytopenia and a hypocellular bone marrow, is effectively treated by immunosuppressive therapy, usually a combination of antithymocyte globulin (...

Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders

This study will use single photon emission computed tomography (SPECT) to determine what areas of the brain are responsible for paroxysmal hyperkinetic movement disorders. Patients with t...

Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria

This study will examine blood cells of patients with paroxysmal nocturnal hemoglobinuria (PNH) after they receive a blood transfusion to determine if certain proteins (GPI-linked proteins)...

Medical and Biotech [MESH] Definitions

Myoxidae

A family of nocturnal rodents, similar in appearance to SQUIRRELS, but smaller. There are 28 species, half of which are found in Africa.

Paroxysmal Hemicrania

A primary headache disorder that is similar to the CLUSTER HEADACHE with unilateral head pain, but differs by its multiple short severe attacks. It is usually seen in females, and may be responsive to non-steroidal-anti-inflammatory drugs (NSAIDS).

Nocturnal Enuresis

Involuntary discharge of URINE during sleep at night after expected age of completed development of urinary control.

Quinine

An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood.

Restless Legs Syndrome

A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep. Complying with an irresistible urge to move the affected limbs brings temporary relief. Sleep may become disrupted, resulting in excessive daytime hypersomnolence. This condition may be associated with UREMIA; DIABETES MELLITUS; and rheumatoid arthritis. Restless Legs Syndrome differs from NOCTURNAL MYOCLONUS SYNDROME in that in the latter condition the individual does not report adverse sensory stimuli and it is primarily a sleep-associated movement disorder. (Adams et al., Principles of Neurology, 6th ed, p387; Schweiz Rundsch Med Prax 1997 Apr 30;86(18):732-736)

Search BioPortfolio:
Advertisement
review and buy Paroxysmal Nocturnal Hemoglobinuria PNH market research data and corporate reports here

Channels Quicklinks

Advertisement